US CHPA warns of cough medicine abuse by teenagers

11 December 2006

The US Consumer Healthcare Products Association has rounded on the "troubling trend of teenagers taking vast amounts of otherwise safe medicines, both prescription and over-the-counter, to get high." The Washington DC-headquartered group issued its warning following the publication, in the Archives of Pediatrics & Adolescent Medicine, of a report on the abuse of over-the-counter cough medicines containing dextromethorphan by teenagers in California.

Linda Suydam, president of the CHPA, said that the group "strongly agrees with the report's conclusion of increasing awareness and education among health care providers, manufacturers and retailers." She added that the "CHPA supports many retailers' efforts to prevent the sale of dextromethorphan-containing medicines to those under the age of 18."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight